FindTrial
Sign In

The analgesic effect and Gastrointestinal impacts of Butorphanol for the patients with postoperative intestina in ICU

The analgesic effect and Gastrointestinal impacts of Butorphanol for the patients with postoperative intestina in ICU

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17011031
Enrollment
Unknown
Registered
2017-03-31
Start date
2017-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Butorphanol Tartrate

Interventions

control group:fentanyl
treatment group :Butorphanol tartrate

Sponsors

Zhongnan hospital of wuhan university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Bowel surgery patients inICU; 2. Aged 18-70 years old; 3. the weight from 45 to 80kg; 4. ASA I-II.

Exclusion criteria

Exclusion criteria: 1. The people that is allergic for bhutto; 2. Long-term application of narcotic analgesics, and sedatives, antidepressants, nonsteroidal anti-inflammatory drugs (nsaids); 3. Despite using vascular drugs, there is still a systemic hypotension; 4. The patients with acute severe craniocerebral injury; 5. Serious heart, lung, liver and kidney function abnormal; 6. Nearly within three months in other clinical researchers; 7. Researchers think that is not suitable for clinical subjects.

Design outcomes

Primary

MeasureTime frame
Nausea and vomiting score;Plasma motilin;endotoxin;d-lactic acid;diamine oxidase;bowel sound;—

Contacts

Public ContactBo Hu

Zhongnan hospital of wuhan university

Hobbier1979@163.com+86 18062603223

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026